These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20812143)

  • 1. Network biology as a new approach to drug discovery.
    Lowe JA; Jones P; Wilson DM
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):524-6. PubMed ID: 20812143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the role of network and systems biology in drug discovery.
    Pujol A; Mosca R; Farrés J; Aloy P
    Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cause-effect relationships in medicine: a protein network perspective.
    Fliri AF; Loging WT; Volkmann RA
    Trends Pharmacol Sci; 2010 Nov; 31(11):547-55. PubMed ID: 20810173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network systems biology for drug discovery.
    Arrell DK; Terzic A
    Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 8. Deploying continuous improvement across the drug discovery value chain.
    Walker SM; Davies BJ
    Drug Discov Today; 2011 Jun; 16(11-12):467-71. PubMed ID: 21443967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology impact on antiepileptic drug discovery.
    Margineanu DG
    Epilepsy Res; 2012 Feb; 98(2-3):104-15. PubMed ID: 22055355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
    Schrattenholz A; Groebe K; Soskic V
    Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 16. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Network pharmacology and drug discovery].
    Wang J; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):241-5. PubMed ID: 22066413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based drugs and biomarkers.
    Erler JT; Linding R
    J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
    Woosley RL; Myers RT; Goodsaid F
    Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.